Your browser doesn't support javascript.
loading
Dismantling Parkinson's disease with herbs: MAO-B inhibitory activity and quantification of chemical constituents using HPLC-MS/MS of Egyptian local market plants.
Ramadan, Soha; Sabry, Manal M; Saad, Muhammed A; Angeloni, Simone; Sabry, Omar M; Caprioli, Giovanni; El Zalabani, Soheir M.
Afiliação
  • Ramadan S; Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo, Egypt.
  • Sabry MM; Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo, Egypt.
  • Saad MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Angeloni S; School of Pharmacy, New Giza University, Giza, Egypt.
  • Sabry OM; School of Pharmacy, University of Camerino, Camerino, Italy.
  • Caprioli G; RICH - Research and Innovation Coffee Hub, Macerata, Italy.
  • El Zalabani SM; Department of Pharmacognosy, College of Pharmacy, Cairo University, Cairo, Egypt.
Nat Prod Res ; 36(22): 5766-5771, 2022 Nov.
Article em En | MEDLINE | ID: mdl-34894897
ABSTRACT
Withania somnifera, Angelica sinensis, Glycyrrhiza glabra, and Simmondsia chinensis were acquired from the Egyptian market, profiled for their chemical constituents, screened for the in-vitro MAO-B inhibitory activity and evaluated for the total phenolic content. Thirty compounds were characterized in the selected herbs using HPLC-MS/MS. In-vitro MAO-B inhibitory activity and total phenolic content of the acquired herbs were compared with those of a prepared herbal formula consisting of a mixture of equal amounts of the four mentioned herbs. The most potent MAO-B inhibitory activity was exerted by the methanol extract of the prepared formula (IC50 of 712.19 ± 13.90 ng/mL) compared to selegiline (IC50 of 581.69 ± 11.35 ng/mL). The highest value of the total phenolic content was shown by Angelica sinensis methanolic extract (76.15 ± 0.1 mg/g) followed by Glycyrrhiza glabra methanolic extract (65.74 ± 0.1 mg/g), then the mixture's methanolic extract of the four herbs (37.04 ± 0.1 mg/g).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Monoaminoxidase Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Monoaminoxidase Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article